https://www.selleckchem.com/pr....oducts/gpr84-antagon
28). In a Cox regression analysis, the variable "presenting untreated episodes of slow VT" was not able to predict mortality. However, being in sinus rhythm (vs. atrial fibrillation, OR 0.31, p = 0.009), narrower QRS (OR 1.036, p = 0.037) and diabetes (OR 4.673, p = 0.049) appropriately predict survival. Untreated slow VT does not significantly worsen patient prognosis. Our results support the limitation of therapies to ATP only, thus avoiding therapies that have been associated with increased risk of morbidity and mortality.
Like
Comment
Share
